
Overview
Auralab360 is a Polish dietary supplement manufacturer offering contract manufacturing, R&D formulation development and private-label brand support. The company manages the process from concept to finished product, including low production minimums and HACCP and GMP standards.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 32 days early.
- 202514/07/2026
- 202415/07/2025
- 202310/04/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Supplement formulation development
- Contract manufacturing of supplements
- Supplement packaging
- Private-label supplements
Websites
- auralab360.plProducent suplementów diety dla Twojej marki – AuraLab360WordPress 6.9ElementorGoogle Tag ManagerYoast SEOLLiteSpeed
- micromeds.plmicromedsShopifyCloudflare
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Marcin Ryćko age 42 | 2,500 | $33,765.53 | 25% |
Karol Wojciech Sadłowski age 30 | 2,500 | $33,765.53 | 25% |
Mateusz Tupczyński age 35 | 2,500 | $33,765.53 | 25% |
Wiktor Mirosław Walczak age 32 | 2,500 | $33,765.53 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-06-12.
83 1090 1014 0000 0001 5439 3824
81 1090 1014 0000 0001 5439 3569
63 1090 1014 0000 0001 5439 3796
Debt
No entries in the National Debtors Register (KRZ).
Secured liabilities
| Type | Secures | |
|---|---|---|
Promissory note | Loans and borrowings |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 29, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $6,529$6,529 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Laborell sp. z o.o. | $5,155,995.80 | laborell.pl | ||
| H+B Group sp. z o.o. | $3,806,379.96 | hbgroup.global | ||
| Biocorpo sp. z o.o. | $2,454,768.74 | biocorpo.pl | ||
| Establo Pharma sp. z o.o. | $2,204,113.57 | establopharma.com | ||
| Pharma Dot sp. z o.o. | $1,653,106.12 | pharmadot.pl | ||
| Fitmax sp. z o.o. | $1,204,356.83 | fitmax.com.pl | ||
| Bionatur sp. z o.o. + limited partnership | $1,192,779.68 | bionatur.pl | ||
| Symbio-Lab sp. z o.o. | $920,360.37 | symbio-lab.com | ||
| Tifarm sp. z o.o. | $598,873.98 | tifarm.pl | ||
| KE Pharma Spółka z Ograniczoną Odpowiedzialością sp. z o.o. | $499,386.90 | kepharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-03-20 | Address change (Ul. Przyjaciół 30/2, 05-825, Książenice → Ul. Zacisze 1, 05-552, Łazy) | |
| 2026-03-20 | Share capital increase (5,000.00 PLN → 500,000.00 PLN) | |
| 2026-03-20 | Name change (Aura Group → Auralab360) | |
| 2026-03-20 | PKD change (Removed: 47.19.Z, 81; Added: 10.89.A, 11, 46) | |
| 2023-05-31 | Entered in the register |
FAQ
Last updated: 2026-07-30